Volcano Announces FDA 510(k) Clearance Of Revolution Rotational Catheter And FFR For The S5i Integrated IVUS Console
Feb 8th 2008Drug InformationMRI / PET / Ultrasound
Volcano Corporation (Nasdaq: VOLC), a leading manufacturer of intravascular ultrasound (IVUS) and functional measurement (FM) technology, announced FDA 510(k) clearance of the s5-Revo and s5-FFR (fractional flow reserve) options. These two new product offerings now enable rotational IVUS and FFR to operate on the same integrated Volcano s5 Imaging System as Volcano’s previous line of phased array IVUS catheters and functionality.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.